Last reviewed · How we verify
L+E mandibular anesthesia
L+E mandibular anesthesia is a local anesthetic formulation designed to provide regional anesthesia of the mandibular nerve for dental and oral surgical procedures.
L+E mandibular anesthesia is a local anesthetic formulation designed to provide regional anesthesia of the mandibular nerve for dental and oral surgical procedures. Used for Mandibular nerve block for dental anesthesia, Regional anesthesia for oral and maxillofacial surgery.
At a glance
| Generic name | L+E mandibular anesthesia |
|---|---|
| Sponsor | University of Belgrade |
| Drug class | Local anesthetic |
| Modality | Small molecule |
| Therapeutic area | Anesthesia / Dentistry |
| Phase | Phase 3 |
Mechanism of action
This formulation combines local anesthetic agents (likely lidocaine and epinephrine based on the 'L+E' designation) to block nerve conduction in the mandibular division of the trigeminal nerve, producing sensory anesthesia of the lower jaw, teeth, and associated tissues. The epinephrine component acts as a vasoconstrictor to prolong anesthetic duration and reduce systemic absorption of the local anesthetic agent.
Approved indications
- Mandibular nerve block for dental anesthesia
- Regional anesthesia for oral and maxillofacial surgery
Common side effects
- Transient paresthesia
- Hematoma at injection site
- Temporary numbness beyond intended duration
- Allergic reaction (rare with amide anesthetics)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- L+E mandibular anesthesia CI brief — competitive landscape report
- L+E mandibular anesthesia updates RSS · CI watch RSS
- University of Belgrade portfolio CI